Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Multicenter, Double-blinded Clinical Trial of SP160412 in the Temporary Relief of Mild to Moderate (i.e,First Degree) Sunburn

NCT03332524 is registered in ClinicalTrials.gov with Sephoris Pharmaceuticals LLC as lead sponsor.

NCT NCT03332524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03332524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Multicenter, Double-blinded Clinical Trial of SP160412 in the Temporary Relief of Mild to Moderate (i.e,First Degree) Sunburn
Lead sponsor
Sephoris Pharmaceuticals LLC
Phase
Phase 2
Overall status
Terminated
Start date
January 15, 2018
Completion date
September 25, 2019
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sunburn